Literature DB >> 19661532

Established psoriatic arthritis: clinical aspects.

Philip S Helliwell1.   

Abstract

Thirty-five years after the hallmark "Moll and Wright" publication, the rheumatology community continues to debate both classification criteria and subgroup analysis of this fascinating yet heterogeneous disease, psoriatic arthritis (PsA). Although Moll and Wright noted the predominant subgroup to be oligoarticular, using tighter definitions for each of the subgroups, historical archives suggest that a majority of their patients had polyarticular disease. One subgroup, arthritis mutilans, remains to be defined clinically, but data from the CASPAR study have been useful as a starting point. Both dactylitis and enthesitis are hallmark features of PsA, and new data on these manifestations are appearing. Dactylitis appears to be a severity marker not only within the affected digit but for the disease as a whole. Enthesitis remains an elusive clinical feature: recent data confirmed the poor association between clinical and ultrasonographic enthesitis in PsA. Finally, spinal disease in PsA is qualitatively and quantitatively different from classical ankylosing spondylitis, and a new scoring system combines elements of the BASRI and mSASSS to give a new modified index.

Entities:  

Mesh:

Year:  2009        PMID: 19661532     DOI: 10.3899/jrheum.090215

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  6 in total

1.  Innovations in Psoriasis Management: Based on Selected Presentations from the Symposium for Cosmetic Advances & Laser Education (SCALE) Virtual Congress-July 24 to 26, 2020.

Authors:  Jo Ann Lequang
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

2.  Extra-articular manifestations in psoriatic arthritis patients.

Authors:  Rosario Peluso; Salvatore Iervolino; Maria Vitiello; Vincenzo Bruner; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2014-05-08       Impact factor: 2.980

3.  Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis.

Authors:  Kristina Juneblad; Martin Johansson; Solbritt Rantapää-Dahlqvist; Gerd-Marie Alenius
Journal:  Arthritis Res Ther       Date:  2011-03-16       Impact factor: 5.156

Review 4.  Diagnosing Psoriatic Arthritis from the Dermatologist's View.

Authors:  Hyun-Ho Cho; Byung-Soo Kim
Journal:  J Lifestyle Med       Date:  2013-09-30

Review 5.  Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Authors:  Rosario Peluso; Giovanni Cafaro; Alessandro Di Minno; Salvatore Iervolino; Pasquale Ambrosino; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 3.650

6.  Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes.

Authors:  Iain B McInnes; Laura M Sawyer; Kristen Markus; Corinne LeReun; Celia Sabry-Grant; Philip S Helliwell
Journal:  RMD Open       Date:  2022-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.